Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics

Andrea Sottoriva, Inmaculada Spiteri, Sara G.M. Piccirillo, Anestis Touloumis, V. Peter Collins, John C. Marioni, Christina Curtis, Colin Watts, Simon Tavaré

Research output: Contribution to journalArticle

694 Citations (Scopus)

Abstract

Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis and a lack of effective therapeutic options. Accumulating evidence suggests that intratumor heterogeneity likely is the key to understanding treatment failure. However, the extent of intratumor heterogeneity as a result of tumor evolution is still poorly understood. To address this, we developed a unique surgical multisampling scheme to collect spatially distinct tumor fragments from 11 GB patients. We present an integrated genomic analysis that uncovers extensive intratumor heterogeneity, with most patients displaying different GB subtypes within the same tumor. Moreover, we reconstructed the phylogeny of the fragments for each patient, identifying copy number alterations in EGFR and CDKN2A/B/p14ARF as early events, and aberrations in PDGFRA and PTEN as later events during cancer progression. We also characterized the clonal organization of each tumor fragment at the singlemolecule level, detectingmultiple coexisting cell lineages.Our results reveal the genome-wide architecture of intratumor variability in GB across multiple spatial scales and patient-specific patterns of cancer evolution, with consequences for treatment design.

Original languageEnglish (US)
Pages (from-to)4009-4014
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume110
Issue number10
DOIs
StatePublished - Mar 5 2013

Fingerprint

Glioblastoma
Neoplasms
Tumor Suppressor Protein p14ARF
Cell Lineage
Phylogeny
Treatment Failure
Genome
Brain
Therapeutics

Keywords

  • High grade glioma
  • Tumor progression

ASJC Scopus subject areas

  • General

Cite this

Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., ... Tavaré, S. (2013). Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proceedings of the National Academy of Sciences of the United States of America, 110(10), 4009-4014. https://doi.org/10.1073/pnas.1219747110

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. / Sottoriva, Andrea; Spiteri, Inmaculada; Piccirillo, Sara G.M.; Touloumis, Anestis; Collins, V. Peter; Marioni, John C.; Curtis, Christina; Watts, Colin; Tavaré, Simon.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, No. 10, 05.03.2013, p. 4009-4014.

Research output: Contribution to journalArticle

Sottoriva, A, Spiteri, I, Piccirillo, SGM, Touloumis, A, Collins, VP, Marioni, JC, Curtis, C, Watts, C & Tavaré, S 2013, 'Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics', Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 10, pp. 4009-4014. https://doi.org/10.1073/pnas.1219747110
Sottoriva, Andrea ; Spiteri, Inmaculada ; Piccirillo, Sara G.M. ; Touloumis, Anestis ; Collins, V. Peter ; Marioni, John C. ; Curtis, Christina ; Watts, Colin ; Tavaré, Simon. / Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. In: Proceedings of the National Academy of Sciences of the United States of America. 2013 ; Vol. 110, No. 10. pp. 4009-4014.
@article{6927d522d7fc46a1abe023688c3d1233,
title = "Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics",
abstract = "Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis and a lack of effective therapeutic options. Accumulating evidence suggests that intratumor heterogeneity likely is the key to understanding treatment failure. However, the extent of intratumor heterogeneity as a result of tumor evolution is still poorly understood. To address this, we developed a unique surgical multisampling scheme to collect spatially distinct tumor fragments from 11 GB patients. We present an integrated genomic analysis that uncovers extensive intratumor heterogeneity, with most patients displaying different GB subtypes within the same tumor. Moreover, we reconstructed the phylogeny of the fragments for each patient, identifying copy number alterations in EGFR and CDKN2A/B/p14ARF as early events, and aberrations in PDGFRA and PTEN as later events during cancer progression. We also characterized the clonal organization of each tumor fragment at the singlemolecule level, detectingmultiple coexisting cell lineages.Our results reveal the genome-wide architecture of intratumor variability in GB across multiple spatial scales and patient-specific patterns of cancer evolution, with consequences for treatment design.",
keywords = "High grade glioma, Tumor progression",
author = "Andrea Sottoriva and Inmaculada Spiteri and Piccirillo, {Sara G.M.} and Anestis Touloumis and Collins, {V. Peter} and Marioni, {John C.} and Christina Curtis and Colin Watts and Simon Tavar{\'e}",
year = "2013",
month = "3",
day = "5",
doi = "10.1073/pnas.1219747110",
language = "English (US)",
volume = "110",
pages = "4009--4014",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "10",

}

TY - JOUR

T1 - Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics

AU - Sottoriva, Andrea

AU - Spiteri, Inmaculada

AU - Piccirillo, Sara G.M.

AU - Touloumis, Anestis

AU - Collins, V. Peter

AU - Marioni, John C.

AU - Curtis, Christina

AU - Watts, Colin

AU - Tavaré, Simon

PY - 2013/3/5

Y1 - 2013/3/5

N2 - Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis and a lack of effective therapeutic options. Accumulating evidence suggests that intratumor heterogeneity likely is the key to understanding treatment failure. However, the extent of intratumor heterogeneity as a result of tumor evolution is still poorly understood. To address this, we developed a unique surgical multisampling scheme to collect spatially distinct tumor fragments from 11 GB patients. We present an integrated genomic analysis that uncovers extensive intratumor heterogeneity, with most patients displaying different GB subtypes within the same tumor. Moreover, we reconstructed the phylogeny of the fragments for each patient, identifying copy number alterations in EGFR and CDKN2A/B/p14ARF as early events, and aberrations in PDGFRA and PTEN as later events during cancer progression. We also characterized the clonal organization of each tumor fragment at the singlemolecule level, detectingmultiple coexisting cell lineages.Our results reveal the genome-wide architecture of intratumor variability in GB across multiple spatial scales and patient-specific patterns of cancer evolution, with consequences for treatment design.

AB - Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis and a lack of effective therapeutic options. Accumulating evidence suggests that intratumor heterogeneity likely is the key to understanding treatment failure. However, the extent of intratumor heterogeneity as a result of tumor evolution is still poorly understood. To address this, we developed a unique surgical multisampling scheme to collect spatially distinct tumor fragments from 11 GB patients. We present an integrated genomic analysis that uncovers extensive intratumor heterogeneity, with most patients displaying different GB subtypes within the same tumor. Moreover, we reconstructed the phylogeny of the fragments for each patient, identifying copy number alterations in EGFR and CDKN2A/B/p14ARF as early events, and aberrations in PDGFRA and PTEN as later events during cancer progression. We also characterized the clonal organization of each tumor fragment at the singlemolecule level, detectingmultiple coexisting cell lineages.Our results reveal the genome-wide architecture of intratumor variability in GB across multiple spatial scales and patient-specific patterns of cancer evolution, with consequences for treatment design.

KW - High grade glioma

KW - Tumor progression

UR - http://www.scopus.com/inward/record.url?scp=84874598318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874598318&partnerID=8YFLogxK

U2 - 10.1073/pnas.1219747110

DO - 10.1073/pnas.1219747110

M3 - Article

C2 - 23412337

AN - SCOPUS:84874598318

VL - 110

SP - 4009

EP - 4014

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 10

ER -